Cargando…

Temporal Muscle Thickness is an Independent Prognostic Biomarker in Patients with Glioma: Analysis of 261 Cases

PURPOSE: Temporal muscle thickness (TMT) has been proposed as a novel surrogate marker for skeletal muscle mass in head and neck malignancies. This study investigated the TMT prognostic relevance with gliomas and evaluated the influence of TMT values on survival in patients with gliomas of different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Ou Ying, Teng, Hai Bo, Fu, Sheng Nan, Chen, Yan Zhu, Liu, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402956/ https://www.ncbi.nlm.nih.gov/pubmed/34466032 http://dx.doi.org/10.2147/CMAR.S326232

Ejemplares similares

Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma
por: Furtner, Julia, et al.
Publicado: (2021)

Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model
por: McKelvey, Kelly J., et al.
Publicado: (2020)

Anthracycline-induced cytotoxicity in the GL261 glioma model system
por: Tavener, Amber M., et al.
Publicado: (2021)

Temporal muscle thickness has no prognostic relevance in patients with high-grade glioma compared to functional scales
por: Klingenschmid, Julia, et al.
Publicado: (2023)

Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases
por: Furtner, Julia, et al.
Publicado: (2018)

A therapeutic cancer vaccine against GL261 murine glioma
por: Kindy, Mark S., et al.
Publicado: (2016)

Temporal muscle thickness as an independent prognostic imaging marker in newly diagnosed glioblastoma patients: A validation study
por: Broen, Martinus P G, et al.
Publicado: (2022)

GNG5 is an unfavourable independent prognostic indicator of gliomas
por: Yang, Biao, et al.
Publicado: (2020)

Health Tract, No. 261: Boils
Publicado: (1866)

Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas
por: Feldman, Lisa A., et al.
Publicado: (2017)

Poster 261: Increased TT-TG and Tibial Slope are Independent Predictors of ACLR Failure
por: Lee, Eric, et al.
Publicado: (2022)

Temporal muscle thickness and area are an independent prognostic factors in patients aged 75 or younger with aneurysmal subarachnoid hemorrhage treated by clipping
por: Katsuki, Masahito, et al.
Publicado: (2021)

A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model
por: Towner, Rheal A., et al.
Publicado: (2015)

PMM no. 26.1 & 4.2
Publicado: (1981)

Anti-PD-1 checkpoint blockade monotherapy in the orthotopic GL261 glioma model: the devil is in the detail
por: Tritz, Zachariah P, et al.
Publicado: (2021)

Oral health and temporal muscle thickness
por: Gonçalves, Ramon Cesar G., et al.
Publicado: (2021)

Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells
por: Clark, Aaron J, et al.
Publicado: (2014)

GL261 luciferase-expressing cells elicit an anti-tumor immune response: an evaluation of murine glioma models
por: Sanchez, Victoria E., et al.
Publicado: (2020)

KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4
por: Sun, Lihua, et al.
Publicado: (2016)

261. Adaptive Immunosuppression in Children with Septic Shock
por: Cruz Vidal, Diego A, et al.
Publicado: (2023)

Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas
por: Enríquez Pérez, Julio, et al.
Publicado: (2020)

Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma
por: Zhuo, Shenghua, et al.
Publicado: (2023)

Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas
por: Sun, Chao, et al.
Publicado: (2021)

Prognostic and Predictive Biomarkers in Gliomas
por: Śledzińska, Paulina, et al.
Publicado: (2021)

Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8(+) T-cell responses and immune memory
por: Wu, Junjie, et al.
Publicado: (2015)

Author Correction: GL261 luciferase-expressing cells elicit an anti-tumor immune response: an evaluation of murine glioma models
por: Sanchez, Victoria E., et al.
Publicado: (2022)

Circadian Clock Genes Act as Diagnostic and Prognostic Biomarkers of Glioma: Clinic Implications for Chronotherapy
por: Chai, Ruihuan, et al.
Publicado: (2022)

Significance of Temporal Muscle Thickness in Chronic Subdural Hematoma
por: Dubinski, Daniel, et al.
Publicado: (2022)

Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson’s Disease
por: Peball, Marina, et al.
Publicado: (2023)

Integrated Transcriptome Analyses and Experimental Verifications of Mesenchymal-Associated TNFRSF1A as a Diagnostic and Prognostic Biomarker in Gliomas
por: Yang, Biao, et al.
Publicado: (2020)

Thick filament mechano-sensing is a calcium-independent regulatory mechanism in skeletal muscle
por: Fusi, L., et al.
Publicado: (2016)

The combined signatures of telomere and immune cell landscape provide a prognostic and therapeutic biomarker in glioma
por: Han, Xu, et al.
Publicado: (2023)

Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients
por: Thomason, Jason WW, et al.
Publicado: (2005)

GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma
por: Huang, Yong, et al.
Publicado: (2022)

High STK40 Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Low-Grade Gliomas
por: Pan, Heyue, et al.
Publicado: (2021)

Temporal muscle thickness predicts mortality in prevalent hemodialysis patients
por: Kara, Ekrem, et al.
Publicado: (2022)

Frailty in cerebellar ischemic stroke—The significance of temporal muscle thickness
por: Dubinski, Daniel, et al.
Publicado: (2023)

Downregulation of STOX1 is a novel prognostic biomarker for glioma patients
por: Jin, Fei-qin, et al.
Publicado: (2021)

Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses
por: Renner, Danielle N., et al.
Publicado: (2015)

Pyk2/FAK Signaling Is Upregulated in Recurrent Glioblastoma Tumors in a C57BL/6/GL261 Glioma Implantation Model
por: Ortiz Rivera, Jescelica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ruc96vhoegbq85t379gq6hnppe